Substantial Clinical Trials Market in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Substantial Clinical Trials Market in Brazil

Substantial Clinical Trials Market in Brazil – Clinical Trials in LATAM

In the realm of medical advancements, clinical trials stand as the cornerstone for progress. Among the countries making significant strides in this arena, Brazil has emerged as a pivotal player in the global clinical trials market. With its vast population, robust healthcare infrastructure, and progressive regulatory environment, Brazil presents a fertile ground for innovative research.

This blog unveils the substantial clinical trials market in Brazil, shedding light on its key attributes, advantages, challenges, and the exciting prospects it holds for the future.

The Brazilian Clinical Trials Landscape

Brazil’s clinical trials sector has experienced exponential growth, gaining recognition as a prominent destination for both domestic and international research initiatives. The country’s diverse patient demographics, combined with its seasoned healthcare professionals, have positioned it as a powerhouse for cutting-edge medical studies.

Advantages of Conducting Clinical Trials in Brazil

  1. Diverse Patient Pool: Brazil’s population encompasses a rich genetic diversity, allowing researchers to study treatment responses across a spectrum of genetic backgrounds and ethnicities. This diversity enhances the generalizability of research findings.
  2. Cost Efficiency: Conducting clinical trials in Brazil is often more cost-effective compared to developed nations. The lower costs stem from factors such as reduced operational expenses, lower labor costs, and favorable exchange rates.
  3. Expertise and Infrastructure: Brazil boasts a skilled pool of experienced medical professionals and researchers who have contributed to a wide range of clinical trials. The country’s well-established medical infrastructure further aids in conducting trials efficiently.
  4. Swift Enrollment: Brazil’s large patient population leads to faster enrollment rates, expediting the trial process and enabling quicker data collection.

Challenges in the Clinical Trials Market

Despite the numerous benefits, Brazil’s clinical trials market faces several challenges that need to be addressed for sustained growth:

  1. Regulatory Complexity: The regulatory landscape in Brazil can be intricate, leading to delays in trial initiation. Harmonization of regulations and expedited approval processes are necessary to attract more international trials.
  2. Infrastructure Disparities: While urban centers in Brazil possess state-of-the-art medical facilities, rural areas might lack the necessary infrastructure. Bridging this gap ensures equitable access for all participants.
  3. Language and Cultural Barriers: Effective communication is vital for successful clinical trials. Language barriers and cultural differences can impact the informed consent process and overall participant engagement.
  4. Data Integrity and Quality: Ensuring data integrity and security is essential for reliable research outcomes. Investments in advanced data management systems and cybersecurity are critical.

Substantial Clinical Trials Market in Brazil

Substantial Clinical Trials Market in Brazil

Substantial Clinical Trials Market in Brazil

Future Prospects and Opportunities

The future of Brazil’s clinical trials market is bright, as the country continues to evolve its healthcare ecosystem. The government’s initiatives to enhance the regulatory framework, coupled with its participation in international research collaborations, enhance Brazil’s credibility on the global stage.

To harness these opportunities, Brazil must proactively address its challenges. Continuous efforts to streamline regulations, improve healthcare access, and invest in professional training will foster an environment that nurtures groundbreaking research.


Brazil’s ascent in the clinical trials market underscores its commitment to medical innovation and patient welfare. The nation’s expansive patient diversity, cost-effectiveness, expert researchers, and evolving regulatory landscape position it as a pivotal force in global clinical research. While challenges exist, they are not insurmountable, and with concerted efforts, Brazil can solidify its role as a substantial contributor to medical advancements.

As the country continues its journey of growth and development, its contributions to clinical research are poised to have a profound and lasting impact on the global healthcare landscape. Brazil stands as a beacon of promise, exemplifying how a nation’s dedication to research can drive transformative changes for the betterment of humanity’s health and well-being.


Substantial Clinical Trials Market in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Substantial Clinical Trials Market in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Substantial Clinical Trials Market in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Substantial Clinical Trials Market in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Substantial Clinical Trials Market in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Substantial Clinical Trials Market in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Substantial Clinical Trials Market in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Substantial Clinical Trials Market in Brazil

The Cohortias Team

Substantial Clinical Trials Market in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Substantial Clinical Trials Market in Brazil

Network & Partnerships